Form 4: Prothena COO Brandon Smith Acquires 130,000 Ordinary Shares

Sentiment:

Insider Transaction Report


Prothena's Chief Operating Officer, Brandon S. Smith, acquired 130,000 ordinary shares of the company at no cost, increasing his direct beneficial ownership.

Summary

  • Brandon S. Smith, Chief Operating Officer of Prothena Corp Public Ltd Co, acquired 130,000 ordinary shares.
  • The acquisition occurred on July 28, 2025.
  • The shares were acquired at a price of $0 per share, indicating an equity grant or award.
  • Following this transaction, Mr. Smith directly beneficially owns 130,000 ordinary shares.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned acquisition.

Sentiment

Score: 7

Explanation: The acquisition of 130,000 shares by the Chief Operating Officer, likely as an equity grant, is generally viewed positively as it aligns management's interests with shareholders. This is a routine insider transaction and does not indicate any immediate concerns.

Positives

  • Chief Operating Officer Brandon S. Smith acquired 130,000 ordinary shares, which aligns management interests with shareholders.
  • The acquisition at a price of $0 suggests an equity grant, a common form of executive compensation that incentivizes long-term performance.

Negatives

  • No negative information was disclosed in this filing.

Risks

  • No specific risks were disclosed in this filing.

Future Outlook

This filing, a Form 4, does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

  • No direct management comments or notable quotes were included in this Form 4 filing.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends. It is a routine disclosure of executive equity compensation.

Comparison to Industry Standards

  • This filing is a standard insider transaction report (Form 4) and does not contain information for comparison to industry-specific benchmarks or competitor results.

Management Changes

RolePrevious PersonNew PersonEffective DateReason

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment

Legal Proceedings

  • No legal proceedings or regulatory matters were disclosed in this filing.

Related Party Transactions

  • The acquisition of shares by the Chief Operating Officer represents a standard equity compensation transaction between the company and a related party.

Stakeholder Impact

  • Shareholders may view the Chief Operating Officer's acquisition of shares positively, as it increases management's direct stake in the company, aligning their interests with shareholder value.

Next Steps

  • This Form 4 filing does not specify future actions, events, or milestones for the company.

Key Dates

DateDescription
07/28/2025Date of earliest transaction for the acquisition of 130,000 ordinary shares.
07/30/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 reports a routine equity grant to a key executive, which is a positive for aligning interests but does not provide sufficient new information to alter an investment thesis. Investors should hold and monitor broader company performance and market conditions.

Keywords

Prothena, PRTA, Form 4, insider transaction, share acquisition, Brandon S. Smith, Chief Operating Officer, equity grant, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.